P. Chollet
Impact in
- Oncology top 0.5%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 121
- Cancer Treatment and Pharmacology 72
- Colorectal Cancer Treatments and Studies 23
- HER2/EGFR in Cancer Research 21
-
- Breast Cancer Treatment Studies 73
- Co-authors
- Xavier Durando (52 shared papers)Catherine Abrial (50 shared papers)H. Curé (36 shared papers)Françis Lévi (11 shared papers)Marie‐Ange Mouret‐Reynier (41 shared papers)B Perpoint (4 shared papers)Rachid Zidani (4 shared papers)Frédérique Penault‐Llorca (37 shared papers)
In The Last Decade
P. Chollet
232 papers receiving 8.3k citations
P. Chollet's Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 3.9k
- Cancer Research 2.1k
- Molecular Medicine 303
- Endocrine and Autonomic Systems 365
- Pathology and Forensic Medicine 857
Countries citing papers authored by P. Chollet
This map shows the geographic impact of P. Chollet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Chollet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Chollet more than expected).
Fields of papers citing papers by P. Chollet
This network shows the impact of papers produced by P. Chollet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Chollet. The network helps show where P. Chollet may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Chollet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 242 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer Hit paper breakdown → | 2000 | 1103 |
| 2 | Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Hit paper breakdown → | 2011 | 817 |
| 3 | 1994 | 321 | |
| 4 | 1986 | 320 | |
| 5 | 2010 | 303 | |
| 6 | Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. | 1993 | 215 |
| 7 | 2002 | 207 | |
| 8 | 2009 | 189 | |
| 9 | 1993 | 188 | |
| 10 | 2003 | 171 | |
| 11 | 1993 | 163 | |
| 12 | 1996 | 124 | |
| 13 | 2016 | 114 | |
| 14 | 1999 | 107 | |
| 15 | 2007 | 103 | |
| 16 | 2007 | 97 | |
| 17 | 2010 | 92 | |
| 18 | 1997 | 92 | |
| 19 | 2003 | 88 | |
| 20 | 1995 | 87 |
About P. Chollet
P. Chollet is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 242 papers that have together received 8.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (73 papers), Cancer Treatment and Pharmacology (72 papers), Colorectal Cancer Treatments and Studies (23 papers), Breast Lesions and Carcinomas (22 papers), HER2/EGFR in Cancer Research (21 papers), Estrogen and related hormone effects (13 papers), Advanced Breast Cancer Therapies (13 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Oncology (3.9k citations), Cancer Research (2.1k citations), Molecular Medicine (303 citations), Endocrine and Autonomic Systems (365 citations) and Pathology and Forensic Medicine (857 citations). P. Chollet has collaborated with scholars based in France, Belgium and Italy. Frequent co-authors include Xavier Durando, Catherine Abrial, H. Curé, Françis Lévi, Marie‐Ange Mouret‐Reynier, B Perpoint, Rachid Zidani, Frédérique Penault‐Llorca, Henri Roché and J Dauplat. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.